Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 13, 2022
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
Tue, July 12, 2022
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
[ Tue, Jul 12th 2022
] - WOPRAI
Tyler Van Buren Initiated (ZNTL) at Buy on, Jul 12th, 2022
Tyler Van Buren of Cowen & Co., Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy on, Jul 12th, 2022.
Tyler has made no other calls on ZNTL in the last 4 months.
There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Tyler's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Tyler
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $72 on, Thursday, May 5th, 2022
- Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $67 on, Tuesday, April 12th, 2022
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $85 on, Tuesday, April 12th, 2022
- Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $67 on, Wednesday, April 6th, 2022
